Arch Therapeutics, Inc.

Company Snapshot: Arch Therapeutics, Inc.

Last Change Volume High Low

Company Overview

Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients. Arch's flagship development stage product candidate, known as AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures.

Featured Documents

Client News

  1. Oct 1 2018 Arch Therapeutics Announces 510(k) Submission to the U.S. FDA for AC5™ Topical Gel
  2. Sep 25 2018 Arch Therapeutics to Provide Corporate Update at the Ladenburg Thalmann 2018 Healthcare Conference on Tuesday, October 2, 2018
  3. Sep 5 2018 Arch Therapeutics Reports Topline Results from Skin Sensitization Study of AC5
  4. Aug 28 2018 Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 20th Annual Global Investment Conference on Wednesday, September 5, 2018
  5. Aug 16 2018 Arch Therapeutics Announces Poster Presentation at the 2018 Military Health System Research Symposium on Tuesday, August 21, 2018